发明授权
- 专利标题: Piperazino-dihydrothienopyrimidine derivatives
- 专利标题(中): 哌嗪二氢噻吩并嘧啶衍生物
-
申请号: US13911712申请日: 2013-06-06
-
公开(公告)号: US09090626B2公开(公告)日: 2015-07-28
- 发明人: Pascale Pouzet , Christoph Hoenke , Peter Nickolaus , Rolf Goeggel , Thomas Fox , Dennis Fiegen , Klaus Klinder
- 申请人: Pascale Pouzet , Christoph Hoenke , Peter Nickolaus , Rolf Goeggel , Thomas Fox , Dennis Fiegen , Klaus Klinder
- 申请人地址: DE Ingelheim am Rhein
- 专利权人: Boehringer Ingelheim International GmbH
- 当前专利权人: Boehringer Ingelheim International GmbH
- 当前专利权人地址: DE Ingelheim am Rhein
- 代理商 Michael P. Morris; Timothy X. Witkowski
- 优先权: EP07118906 20071019
- 主分类号: C07D495/04
- IPC分类号: C07D495/04 ; A61K31/519 ; C07D519/00
摘要:
A method for treating diseases associated with the inhibition of phosphodiesterase 4 (PDE4) enzyme in a patient comprising administering to the patient in need thereof a therapeutically effective amount of a dihydrothienopyrimidinesulphoxide of formula 1, as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof
公开/授权文献
- US20130274264A1 PIPERAZINO-DIHYDROTHIENOPYRIMIDINE DERIVATIVES 公开/授权日:2013-10-17